Skip to main content

Friday, February 4th, 2022

Biofilm Control announces the publication of the results of its pilot study demonstrating the clinical relevance of its Antibiofilmogram® test, the first test providing the clinician with essential information on the effectiveness of antibiotics against biofilm.

The pilot study, carried out in collaboration with clinicians from the CHU of Nîmes, the International Center for Research in Infectiology (CIRI), the Hospices Civils de Lyon and the CHU of Nantes, focused on a major public health problem, the foot ulcer in diabetic patients, one of the most frequently encountered complications (40 to 80% of patients).

 

Access the press release

 

Contact us: contact@biofilmcontrol.com